Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.
作者信息
Saif Muhammad Wasif, Merritt James, Robbins Joan, Stewart Jeffrey, Schupp Joachim
机构信息
Developmental Therapeutics Program, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
出版信息
Clin Colorectal Cancer. 2006 Sep;6(3):229-34. doi: 10.3816/CCC.2006.n.042.
PMID:17026795
Abstract
摘要
Zotero 插件